疑似白喉类毒素和破伤风类毒素（dTdap）加强疫苗诱发的体位性直立性心动过速综合征（POTS）。
Suspected Diphtheria Toxoid and Tetanus Toxoid (dTdap) Booster Vaccine-Induced Postural Orthostatic Tachycardia Syndrome (POTS).
作者信息
Katwaroo Arun R, Chandolu Krishna Mohan, Seecheran Valmiki K, Ramcharan Priya, Seecheran Rajeev V, Giddings Stanley, Bhagwandass Neal, Seecheran Naveen A
机构信息
Internal Medicine, Trinidad Institute of Medical Technology, St. Augustine, TTO.
Public Health, Eastern Regional Health Authority, Sangre Grande, TTO.
出版信息
Cureus. 2024 Jul 7;16(7):e64008. doi: 10.7759/cureus.64008. eCollection 2024 Jul.
Abstract
We describe a case of a 40-year-old South Asian woman who presented with symptoms suggestive of postural orthostatic tachycardia syndrome (POTS) following a diphtheria toxoid and tetanus toxoid (dTdap) booster vaccination administered one week prior. The patient's POTS responded favorably to treatment with low-dose fludrocortisone and ivabradine. Clinicians should maintain a high index of suspicion for POTS as a possible vaccine adverse event (VAE) post-dTdap booster inoculation and be aware of appropriate management strategies.
摘要
我们描述了一例40岁的南亚女性病例，该患者在一周前接种白喉类毒素和破伤风类毒素（dTdap）加强疫苗后，出现了提示体位性直立性心动过速综合征（POTS）的症状。患者的POTS对小剂量氟氢可的松和伊伐布雷定治疗反应良好。临床医生应高度怀疑POTS是dTdap加强接种后可能出现的疫苗不良事件（VAE），并了解适当的管理策略。
相似文献
1
Suspected Diphtheria Toxoid and Tetanus Toxoid (dTdap) Booster Vaccine-Induced Postural Orthostatic Tachycardia Syndrome (POTS).
Cureus. 2024 Jul 7;16(7):e64008. doi: 10.7759/cureus.64008. eCollection 2024 Jul.
2
Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome.
Cureus. 2023 Jan 26;15(1):e34236. doi: 10.7759/cureus.34236. eCollection 2023 Jan.
3
Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
Vaccine. 2020 Oct 14;38(44):6914-6921. doi: 10.1016/j.vaccine.2020.08.058. Epub 2020 Sep 2.
4
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Vaccine. 2023 Nov 2;41(46):6810-6819. doi: 10.1016/j.vaccine.2023.09.060. Epub 2023 Oct 10.
5
Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
Eur J Pediatr. 2006 Jan;165(1):14-8. doi: 10.1007/s00431-005-1763-3. Epub 2005 Oct 26.
6
Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination.
Front Neurol. 2023 Aug 16;14:1221518. doi: 10.3389/fneur.2023.1221518. eCollection 2023.
7
Antibody persistence to diphtheria toxoid, tetanus toxoid, antigens, and type b following primary and first booster with pentavalent versus hexavalent vaccines.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2352909. doi: 10.1080/21645515.2024.2352909. Epub 2024 May 16.
8
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
J Adolesc Health. 2017 Nov;61(5):577-582. doi: 10.1016/j.jadohealth.2017.08.004.
9
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
Expert Rev Vaccines. 2023 Jan-Dec;22(1):278-287. doi: 10.1080/14760584.2023.2188942.
10
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
本文引用的文献
1
Global epidemiology and burden of tetanus from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.
Int J Infect Dis. 2023 Jul;132:118-126. doi: 10.1016/j.ijid.2023.04.402. Epub 2023 Apr 21.
2
Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome.
Cureus. 2023 Jan 26;15(1):e34236. doi: 10.7759/cureus.34236. eCollection 2023 Jan.
3
Diagnosis and management of postural orthostatic tachycardia syndrome.
CMAJ. 2022 Mar 14;194(10):E378-E385. doi: 10.1503/cmaj.211373.
4
Dysautonomia Following Tetanus, Diphtheria, and Pertussis Vaccine (Tdap): The First Case of Extreme Cachexia Caused by Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA Syndrome) in a Human.
Medicina (Kaunas). 2021 Dec 6;57(12):1333. doi: 10.3390/medicina57121333.
5
A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 Vaccine.
Cureus. 2021 May 4;13(5):e14837. doi: 10.7759/cureus.14837.
6
Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients.
Immunol Res. 2021 Apr;69(2):205-211. doi: 10.1007/s12026-021-09185-5. Epub 2021 Mar 30.
7
Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.
J Am Coll Cardiol. 2021 Feb 23;77(7):861-871. doi: 10.1016/j.jacc.2020.12.029.
8
An Unusual Case of Evolving Localized Tetanus Despite Prior Immunization and Protective Antibody Titer.
Cureus. 2020 Jul 31;12(7):e9498. doi: 10.7759/cureus.9498.
9
Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.
Cureus. 2020 Apr 28;12(4):e7868. doi: 10.7759/cureus.7868.
10
Vaccine-Associated Neurological Adverse Events: A Case Report and Literature Review.
Curr Pharm Des. 2020;25(43):4570-4578. doi: 10.2174/1381612825666191119095132.
Zotero 插件